These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 39052567)
1. In silico exploration of deep-sea fungal metabolites as inhibitor of Ebola and Marburg VP35 and VP40. Alanzi AR; Alajmi MF; Al-Dosari MS; Parvez MK; Alqahtani MJ PLoS One; 2024; 19(7):e0307579. PubMed ID: 39052567 [TBL] [Abstract][Full Text] [Related]
2. Integrated Computational Approach for Virtual Hit Identification against Ebola Viral Proteins VP35 and VP40. Mirza MU; Ikram N Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27792169 [TBL] [Abstract][Full Text] [Related]
3. Identification of Prospective Ebola Virus VP35 and VP40 Protein Inhibitors from Myxobacterial Natural Products. Hayat M; Gao T; Cao Y; Rafiq M; Zhuo L; Li YZ Biomolecules; 2024 Jun; 14(6):. PubMed ID: 38927063 [TBL] [Abstract][Full Text] [Related]
4. In silico screening of sugar alcohol compounds to inhibit viral matrix protein VP40 of Ebola virus. Nagarajan N; Yapp EKY; Le NQK; Yeh HY Mol Biol Rep; 2019 Jun; 46(3):3315-3324. PubMed ID: 30982214 [TBL] [Abstract][Full Text] [Related]
5. Herbal Lead as Ideal Bioactive Compounds Against Probable Drug Targets of Ebola Virus in Comparison with Known Chemical Analogue: A Computational Drug Discovery Perspective. Setlur AS; Naik SY; Skariyachan S Interdiscip Sci; 2017 Jun; 9(2):254-277. PubMed ID: 26857866 [TBL] [Abstract][Full Text] [Related]
6. VP40 of the Ebola Virus as a Target for EboV Therapy: Comprehensive Conformational and Inhibitor Binding Landscape from Accelerated Molecular Dynamics. Balmith M; Soliman ME Cell Biochem Biophys; 2017 Mar; 75(1):65-78. PubMed ID: 28144904 [TBL] [Abstract][Full Text] [Related]
7. Chaperone-Mediated Autophagy Protein BAG3 Negatively Regulates Ebola and Marburg VP40-Mediated Egress. Liang J; Sagum CA; Bedford MT; Sidhu SS; Sudol M; Han Z; Harty RN PLoS Pathog; 2017 Jan; 13(1):e1006132. PubMed ID: 28076420 [TBL] [Abstract][Full Text] [Related]
8. Evasion of interferon responses by Ebola and Marburg viruses. Basler CF; Amarasinghe GK J Interferon Cytokine Res; 2009 Sep; 29(9):511-20. PubMed ID: 19694547 [TBL] [Abstract][Full Text] [Related]
9. Impact of Měnglà Virus Proteins on Human and Bat Innate Immune Pathways. Williams CG; Gibbons JS; Keiffer TR; Luthra P; Edwards MR; Basler CF J Virol; 2020 Jun; 94(13):. PubMed ID: 32295912 [TBL] [Abstract][Full Text] [Related]
11. A Novel Ebola Virus VP40 Matrix Protein-Based Screening for Identification of Novel Candidate Medical Countermeasures. Bennett RP; Finch CL; Postnikova EN; Stewart RA; Cai Y; Yu S; Liang J; Dyall J; Salter JD; Smith HC; Kuhn JH Viruses; 2020 Dec; 13(1):. PubMed ID: 33396288 [TBL] [Abstract][Full Text] [Related]
12. Crystal Structure of the Marburg Virus VP35 Oligomerization Domain. Bruhn JF; Kirchdoerfer RN; Urata SM; Li S; Tickle IJ; Bricogne G; Saphire EO J Virol; 2017 Jan; 91(2):. PubMed ID: 27847355 [TBL] [Abstract][Full Text] [Related]
13. Ebola and Marburg virus matrix layers are locally ordered assemblies of VP40 dimers. Wan W; Clarke M; Norris MJ; Kolesnikova L; Koehler A; Bornholdt ZA; Becker S; Saphire EO; Briggs JA Elife; 2020 Oct; 9():. PubMed ID: 33016878 [TBL] [Abstract][Full Text] [Related]
14. Drug targets in infections with Ebola and Marburg viruses. Gene OG; Julia BE; Vanessa MR; Victoria WJ; Thomas GW; Lisa HE Infect Disord Drug Targets; 2009 Apr; 9(2):191-200. PubMed ID: 19275706 [TBL] [Abstract][Full Text] [Related]
15. Flavonoids as Multi-target Inhibitors for Proteins Associated with Ebola Virus: In Silico Discovery Using Virtual Screening and Molecular Docking Studies. Raj U; Varadwaj PK Interdiscip Sci; 2016 Jun; 8(2):132-141. PubMed ID: 26286008 [TBL] [Abstract][Full Text] [Related]